Diagnostics & Informatics Weekly Briefs
Every published Diagnostics & Informatics brief — the week’s developments and what they mean for operators, vendors, and investors.
- Companion diagnostics become commercial platforms, FDA makes AI validation the moat, and pathology consolidatesOctober 12, 2026
- Decentralized diagnostics become workflow platforms, blood screening enters clinical care, and liquid biopsy turns decision supportOctober 5, 2026
- Therapy-Specific Liquid Biopsy, Routed Telepathology, and Workflow-Control AI Tighten Diagnostic ControlSeptember 28, 2026
- Access gates tighten, workflow owners win, and pathology platforms scale across bordersSeptember 21, 2026
- Workflow-embedded diagnostics win, EU access bottlenecks tighten, and biomarker evidence becomes the moatSeptember 14, 2026
- Serial reimbursement, distributed biomarker workflows, and FDA-cleared claims are reshaping diagnostics commercializationAugust 31, 2026
- Workflow interoperability, integrated diagnostics, and embedded governance reshape AI control pointsAugust 24, 2026
- Workflow-specific AI clears first, companion diagnostics gain reimbursed access, and multiomics shifts to deploymentAugust 17, 2026
- Embedded Clinical Workflows, Commercial Validation Infrastructure, and Cloud Teleradiology OrchestrationAugust 10, 2026
- Infrastructure wins in diagnostics, AI embeds in workflows, and serial testing drives oncology revenueAugust 3, 2026
- Reimbursement and validation reshape diagnostics value, AI diagnostics enter regulated territoryJuly 27, 2026